FDA Leadership Shake-Up Continues Amid Push for OTC Drug Expansion
The U.S. Food and Drug Administration (FDA) is experiencing significant leadership changes, with the latest development involving the transfer of Theresa Michele, M.D., who has served as the director of the Office of Nonprescription Drugs for a decade. This move comes just one day after the unexpected retirement of Richard Pazdur, M.D., the newly appointed director of the Center for Drug Evaluation and Research (CDER).
